chr10-27100510-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014915.3(ANKRD26):c.-184G>T variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00478 in 885,920 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0049 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0048 ( 23 hom. )
Consequence
ANKRD26
NM_014915.3 upstream_gene
NM_014915.3 upstream_gene
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.80
Genes affected
ANKRD26 (HGNC:29186): (ankyrin repeat domain containing 26) This gene encodes a protein containing N-terminal ankyrin repeats which function in protein-protein interactions. Mutations in this gene are associated with autosomal dominant thrombocytopenia-2. Pseudogenes of this gene are found on chromosome 7, 10, 13 and 16. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 10-27100510-C-A is Benign according to our data. Variant chr10-27100510-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 434211.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00493 (751/152376) while in subpopulation NFE AF = 0.00563 (383/68034). AF 95% confidence interval is 0.00516. There are 3 homozygotes in GnomAd4. There are 449 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 751 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00493 AC: 751AN: 152258Hom.: 3 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
751
AN:
152258
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00475 AC: 3485AN: 733544Hom.: 23 Cov.: 10 AF XY: 0.00465 AC XY: 1736AN XY: 373312 show subpopulations
GnomAD4 exome
AF:
AC:
3485
AN:
733544
Hom.:
Cov.:
10
AF XY:
AC XY:
1736
AN XY:
373312
Gnomad4 AFR exome
AF:
AC:
16
AN:
17442
Gnomad4 AMR exome
AF:
AC:
20
AN:
19272
Gnomad4 ASJ exome
AF:
AC:
1
AN:
15488
Gnomad4 EAS exome
AF:
AC:
0
AN:
32588
Gnomad4 SAS exome
AF:
AC:
0
AN:
51866
Gnomad4 FIN exome
AF:
AC:
730
AN:
29574
Gnomad4 NFE exome
AF:
AC:
2581
AN:
529384
Gnomad4 Remaining exome
AF:
AC:
136
AN:
35398
Heterozygous variant carriers
0
189
379
568
758
947
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00493 AC: 751AN: 152376Hom.: 3 Cov.: 34 AF XY: 0.00603 AC XY: 449AN XY: 74512 show subpopulations
GnomAD4 genome
AF:
AC:
751
AN:
152376
Hom.:
Cov.:
34
AF XY:
AC XY:
449
AN XY:
74512
Gnomad4 AFR
AF:
AC:
0.000769268
AN:
0.000769268
Gnomad4 AMR
AF:
AC:
0.00182863
AN:
0.00182863
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0.0271923
AN:
0.0271923
Gnomad4 NFE
AF:
AC:
0.00562954
AN:
0.00562954
Gnomad4 OTH
AF:
AC:
0.00331126
AN:
0.00331126
Heterozygous variant carriers
0
39
78
116
155
194
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Oct 25, 2018
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Thrombocytopenia 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Apr 29, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at